Coya Therapeutics, Inc. (COYA) Tops Q3 EPS by 46c
Tweet
Share
E-mailGet Alerts COYA Hot Sheet
Join SI Premium – FREE
Coya Therapeutics, Inc. (NASDAQ: COYA) reported Q3 EPS of ($0.13), $0.46 better than the analyst estimate of ($0.59). Revenue for the quarter came in at $3.56 million, versus $0 reported last year.
For earnings history and earnings-related data on Coya Therapeutics, Inc. (COYA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Reiterates Neutral Rating on Target (TGT)
- Summit Therapeutics (SMMT) Reiterated at Market Outperform by Citizens
- Mizuho Reiterates Outperform Rating on Corteva Inc. (CTVA)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
